ADJUVANT CHEMORADIOTHERAPY AFTER SUBTOTAL OR TOTAL GASTRECTOMY AND D2 LIMPHADENECTOMY INCREASES SURVIVAL IN ADVANCED GASTRIC CANCER?

BACKGROUND: The treatment of advanced gastric cancer with curative intent is essentially surgical and chemoradiotherapy is indicated as neo or adjuvant to control the disease and prolong survival. AIM: To assess the survival of patients undergoing subtotal or total gastrectomy with D2 lymphadenectom...

Descripción completa

Detalles Bibliográficos
Autores principales: ANDREOLLO, Nelson Adami, DRIZLIONOKS, Eric, TERCIOTI-JUNIOR, Valdir, COELHO-NETO, João de Souza, FERRER, José Antonio Possato, CARVALHEIRA, José Barreto Campello, LOPES, Luiz Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Colégio Brasileiro de Cirurgia Digestiva 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918727/
https://www.ncbi.nlm.nih.gov/pubmed/31859917
http://dx.doi.org/10.1590/0102-672020190001e1464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918727/
https://www.ncbi.nlm.nih.gov/pubmed/31859917
http://dx.doi.org/10.1590/0102-672020190001e1464

Ejemplares similares